NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:NPO Petrovax Pharm LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C11162
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:24
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ロシア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
NPO Petrovax Pharm LLC (Petrovax) focuses on the research, development and manufacturing of medicines and vaccines. The company’s expertise spans in producing APIs and liquid, semi-solid, and solid dosage forms in ampoules, plastic containers, vials and disposable syringes. It also provides cosmetic and veterinary products. Petrovax offers products in the therapeutic areas of infection diseases, immunology, urology, gynecology, and reproductive health. The company works in partnership with pharmaceutical companies and research and development institutions to develop new products. It commercializes its products in Ukraine, Belarus, Kazakhstan, Kyrgyzstan, Azerbaijan, Uzbekistan, Georgia, Moldova and Slovakia among others. Petrovax is headquartered in Moscow, Russia.

NPO Petrovax Pharm LLC – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Petrovax Pharm Enters into Cooperation Agreement with Scientific Research Institute of Vaccines 10
Acquisition 11
Interros Acquires Controlling Stake in NPO Petrovax Pharm, Vaccine Maker 11
Russian Authorities Reject Abbott’s Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 12
NPO Petrovax Pharm LLC – Key Competitors 14
NPO Petrovax Pharm LLC – Key Employees 15
NPO Petrovax Pharm LLC – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Legal and Regulatory 17
Oct 18, 2017: Petrovax Pharm successfully certified for ISO 9001:2015 conformity 17
Mar 09, 2017: NPO Petrovax Pharm recertified for Russian GMP conformance of pharmaceutical manufacture and Quality Management System 18
Product News 19
Oct 10, 2017: Innovative thrombolytics for acute myocardial infarction readily accessible for Russian patients 19
May 16, 2017: Commercial batches of localized innovative thrombolytics to be launched to Russian market in June 20
Mar 13, 2017: NPO Petrovax Pharm launched PHARDO system for trial period 22
Other Significant Developments 23
May 06, 2017: Navicon updated CRM system at Petrovax Pharm 23
Appendix 24
Methodology 24
About GlobalData 24
Contact Us 24
Disclaimer 24

List of Tables
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Key Facts 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NPO Petrovax Pharm LLC, Deals By Therapy Area, 2012 to YTD 2018 8
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Petrovax Pharm Enters into Cooperation Agreement with Scientific Research Institute of Vaccines 10
Interros Acquires Controlling Stake in NPO Petrovax Pharm, Vaccine Maker 11
Russian Authorities Reject Abbott's Bid To Acquire 62.5% Stake In Petrovax Pharm, Drug Manufacturer 12
NPO Petrovax Pharm LLC, Key Competitors 14
NPO Petrovax Pharm LLC, Key Employees 15
NPO Petrovax Pharm LLC, Other Locations 16

List of Figures
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
NPO Petrovax Pharm LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[NPO Petrovax Pharm LLC:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • GI Dynamics Inc (GID):医療機器:M&Aディール及び事業提携情報
    Summary GI Dynamics Inc (GI Dynamics) is a clinical stage medical device company that develops and commercializes endoscopy instruments. The company develops EndoBarrier, a device to treat type 2 diabetes and obesity, which is delivered endoscopically. The device imitates the mechanisms of metabolic …
  • Ernst & Young Global Ltd:企業の戦略・SWOT・財務分析
    Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report Summary Ernst & Young Global Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Rafael Pharmaceuticals Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Rafael Pharmaceuticals Inc (Rafael Pharmaceuticals), formerly Cornerstone Pharmaceuticals Inc, is a clinical-stage, metabolic oncology therapeutics company, which focuses to develop and commercialize cancer metabolism based drugs. The company’s lead drug candidate CPI-613 is designed to targ …
  • Gulf Holding Company:企業の戦略的SWOT分析
    Gulf Holding Company - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Freudenberg & Co KG:企業の戦略的SWOT分析
    Freudenberg & Co KG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Goodwin Biotechnology Inc-製薬・医療分野:企業M&A・提携分析
    Summary Goodwin Biotechnology Inc (GBI), a subsidiary of Wallace Pharmaceuticals Pvt Ltd is a healthcare company that develops and manufactures vaccines, monoclonal antibodies, recombinant proteins and bioconjugates. The company offers cell culture, purification, bioconjugation, biosimilars, aseptic …
  • KP Energy Ltd (539686):電力:M&Aディール及び事業提携情報
    Summary KP Energy Ltd (KP Energy) is an alternative energy company that offers power and wind energy solutions. The company provides services such as turnkey solutions, BOT basis services, land acquisition, project development, cost studies, site identification, capacity installations, engineer, pro …
  • James Fisher and Sons Plc (FSJ)-石油・ガス分野:企業M&A・提携分析
    Summary James Fisher and Sons plc (James Fisher) is a service provider that focuses on global marine industry and a specialist supplier of engineering services to the energy industry. The company provides comprehensive services such as design and engineering; inspection and monitoring; lifting and h …
  • Sigla, S.A.:企業の戦略的SWOT分析
    Sigla, S.A. - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • ARxIUM-医療機器分野:企業M&A・提携分析
    Summary ARxIUM, formerly Intelligent Hospital Systems Inc, a subsidiary of Van Humbeck Family, is a medical device company that designs and manufactures automated solutions for the hospital pharmacy. The company’s products include RxWorks pro, workflow, inventory management, IV compounding system, h …
  • UCB SA (UCB)-医療機器分野:企業M&A・提携分析
    Summary UCB SA (UCB) is a biopharmaceutical company that discovers and develops novel medicines and solutions to help treat various diseases. It principally focuses on developing products for the treatment of central nervous system (CNS) and immunology related conditions. The company's key medicines …
  • Egmont International Holding AS:企業の戦略的SWOT分析
    Egmont International Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Celularity Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Celularity Inc (Celularity) is a biotechnology company that develops and commercializes therapeutics derived from the placenta for autoimmune and degenerative diseases, immuno-oncology, and functional regeneration. The company’s pre-clinical and clinical assets include CAR-T cell receptor an …
  • Estee Lauder Companies Inc:企業の戦略・SWOT・財務情報
    Estee Lauder Companies Inc - Strategy, SWOT and Corporate Finance Report Summary Estee Lauder Companies Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and servi …
  • Meiji Holdings Co Ltd (2269):企業の財務・戦略的SWOT分析
    Meiji Holdings Co Ltd (2269) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Telefonica, S.A.:企業の戦略・SWOT・財務情報
    Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report Summary Telefonica, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Sino Hotels (Holdings) Limited:企業の戦略・SWOT・財務分析
    Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report Summary Sino Hotels (Holdings) Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Solco Biomedical Co Ltd (043100)-医療機器分野:企業M&A・提携分析
    Summary Solco Biomedical Co Ltd (Solco) is a medical device company that manufactures surgical instruments. The company develops and produces implants for orthopedics, neurosurgery, surgical instruments and home functional health products. It offers implants, instruments and health care products. So …
  • Theranostics Health Inc:医療機器:M&Aディール及び事業提携情報
    Summary Theranostics Health Inc (Theranostics), a subsidiary of Avant Diagnostics Inc is a healthcare service provider that offers protein based solutions. The company provides protein based discovery and translational research services. Its products include molecular navigation of targeted therapie …
  • Nabriva Therapeutics Plc (NBRV):製薬・医療:M&Aディール及び事業提携情報
    Summary Nabriva Therapeutics Plc (Nabriva) is a biopharmaceutical company that researches and develops antibiotics for the treatment of infections. The company’s product candidate includes lefamulin, a pleuromutilin antibiotic, being developed in both intravenous and oral formulations for the treatm …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆